Additionally, Nrf2 negatively regulates NF-κB signaling, further suppressing pro-inflammatory cytokine production, highlighting its potential as a therapeutic target in asthma and other inflammation-associated diseases [100]. The gene discussed is NFE2L2; the disease is asthma.